Cargando…
Optimal Timing for COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy?
Autores principales: | Sudan, A., Iype, R., Kelly, C., Iqbal, M.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759144/ https://www.ncbi.nlm.nih.gov/pubmed/33402269 http://dx.doi.org/10.1016/j.clon.2020.12.014 |
Ejemplares similares
-
COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy
por: Mungmungpuntipantip, R., et al.
Publicado: (2021) -
Why Coverage of Influenza Vaccine Is Not Enough in Patients Receiving Chemotherapy?
por: Meidani, Mohsen, et al.
Publicado: (2011) -
Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy
por: Yeh, C-H, et al.
Publicado: (2008) -
Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
por: Inaba, Tohru, et al.
Publicado: (2022) -
Is it time to reconsider ring vaccination for COVID-19?
por: McAlister, Vivian C.
Publicado: (2022)